Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
RELATED RESEARCH RESOURCES AND LINKS
ListGraphMap
Displaying 1 - 9 of 9 Projects
Project # Contact PI Funding Organization Fiscal Year
Brain Networks in People with Down syndrome: the effect of AD pathology
GBHI ALZ UK-20-641398 McGlinchey, Eimear Global Brain Health Institute (GBHI)|Alzheimer's Association|Alzheimer's Society 2020
ASSESSMENT AND CHARACTERIZATION OF BIOMARCATORS OF THE PRECLINIC STADIUM OF ALZHEIMER'S DISEASE
EUJPND-SpainISC-BELBIN-1313 BELBIN, OLIVIA INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
ALZHEIMER'S DISEASE AND DOWN SYNDROME. MULTIMODAL STUDIES OF CLEAR LIQUID, MAGNETIC RESONANCE AND PET OF AMYLOID.
EUJPND-SpainISC-BLESA GONZALEZ-1316 BLESA GONZALEZ, RAFAEL INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND LOBULAR DEVELOPMENT FRONTOTEMPORAL (DLFT) - I
EUJPND-SpainISC-GARCIA REDONDO-1337 GARCIA REDONDO, ALBERTO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
CLINICAL PHENOTYPES AND NEW PHYSIOPATHOLOGICAL, DIAGNOSTIC AND PROGNOSTIC BIOMARCATORS IN ALZHEIMER'S DISEASE OF PRECIOUS START AND BEHAVIORAL BEHAVIOR OF FRONTOTEMPORA DEMENTIA
EUJPND-SpainISC-LLADO PLARRUMANI-1350 LLADO PLARRUMANI, ALBERT INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
SYNAPTIC MARKERS IN ALZHEIMER'S DISEASE
EUJPND-SpainISC-LLEO BISA-1351 LLEO BISA, ALBERTO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
STUDY OF BIOMARKERS IN THE CONTINUOUS PATHOLOGICAL EXISTING BETWEEN LATERAL AMIOTROPHIC SCLEROSIS (ELA) AND FRONTOTEMPORAL LOBULAR DEGENERATION (DLFT) -II
EUJPND-SpainISC-OSTA PINZOLAS-1360 OSTA PINZOLAS, ROSARIO INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
BLOOD AND NEUROPHYSIOLOGICAL MARKERS OF THE PROGRESSION OF COGNITIVE DETERIORATION IN PARKINSON'S DISEASE
EUJPND-SpainISC-PAGONABARRAGA MORA-1361 PAGONABARRAGA MORA, JAVIER INSTITUTO DE SALUD CARLOS III. ACCIÓN ESTRATEGICA EN SALUD 2016
Innovative bioassay concepts for Alzheimer’s Disease diagnostics
EUJPND-KU Leuven-Ven-327 Ven, Karen KU Leuven 2016